Thomas Slavin
Impact in
-
- BRCA gene mutations in cancer
- Genomics and Rare Diseases
- Genomic variations and chromosomal abnormalities
-
- Cancer Genomics and Diagnostics
Papers in
- Genetics 4
- BRCA gene mutations in cancer 4
- Genomics and Rare Diseases 2
-
- Cancer Genomics and Diagnostics 2
- Co-authors
- Charité Ricker (1 shared paper)Erin Mundt (1 shared paper)Irene Rainville (1 shared paper)Kathleen R. Blazer (2 shared papers)Jeffrey N. Weitzel (2 shared papers)Susan Manley (1 shared paper)Nanda Singh (1 shared paper)Raúl Méjía (1 shared paper)
- Journals
- Cancer Research (1 paper)JCO Precision Oncology (1 paper)JAMA Oncology (1 paper)Cancer Genetics (1 paper)
- Partner nations
- United StatesPeruMexico
In The Last Decade
Thomas Slavin
4 papers receiving 25 citations
Peers
Comparison fields: 5 of 11
- Genetics 19
- Cancer Research 7
- Pathology and Forensic Medicine 7
- Oncology 8
- Molecular Biology 8
Countries citing papers authored by Thomas Slavin
This map shows the geographic impact of Thomas Slavin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Slavin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Slavin more than expected).
Fields of papers citing papers by Thomas Slavin
This network shows the impact of papers produced by Thomas Slavin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Slavin. The network helps show where Thomas Slavin may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Slavin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 12 | |
| 2 | 2016 | 7 | |
| 3 | 2021 | 5 | |
| 4 | 2018 | 1 |
About Thomas Slavin
Thomas Slavin is a scholar working on Genetics, Cancer Research, Molecular Biology, Pathology and Forensic Medicine and Infectious Diseases, having authored 4 papers that have together received 25 indexed citations. Recurring topics across this work include BRCA gene mutations in cancer (4 papers), Cancer Genomics and Diagnostics (2 papers), Genomics and Rare Diseases (2 papers), DNA Repair Mechanisms (1 paper) and Genetic factors in colorectal cancer (1 paper). The work is most often cited by research in Genetics (19 citations), Cancer Research (7 citations), Pathology and Forensic Medicine (7 citations), Oncology (8 citations) and Molecular Biology (8 citations). Thomas Slavin has collaborated with scholars based in United States, Peru and Mexico. Frequent co-authors include Charité Ricker, Erin Mundt, Irene Rainville, Kathleen R. Blazer, Jeffrey N. Weitzel, Susan Manley, Nanda Singh, Raúl Méjía, Ann S. Hamilton and Lily Hoang. Their work appears in journals such as Cancer Research, JCO Precision Oncology, JAMA Oncology and Cancer Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.